Syneron Bio Signs Strategic Partnership with AstraZeneca
Under this collaboration, AstraZeneca will gain access to Syneron Bio's innovative Synova™ platform, an intelligent and high-throughput macrocyclic peptide drug research and development platform, designed to support the advancements of research programmes exploring possible future treatments of chronic diseases.
- Global Pharma | 24/03/2025 | By Aishwarya | 402
Interviews
Amit Gupta, MD and Chairman, Leeford Healthcare
Leeford is actively expanding its presence in the Core Critical Care segment with the establishment of our own injectable manufacturing unit, said Amit Gupta, MD & Chairman, Leeford Healthcare in an interview wi...
Bobby Abhishek Madaan, Director, Toshi Automation
Our high-speed doors are designed with advanced sensors and automated control systems, allowing them to adapt to changing environmental conditions in real-time, states Bobby Abhishek Madaan, Director, Toshi Automati...
Rudiger Gall, Falgun Jani, Chinmay Korad and Senthil Kumar E, General Manager / VP of Business Development, Business Head-India,Country Head - Pharma, Sr. General Manager, Freudenberg Medical
Freudenberg’s leadership emphasized India’s strategic importance in their global expansion plans. With the country’s pharmaceutical market growing at a CAGR of 12 percent, the company is committed ...
Articles
Beyond the Pill: A Holistic Approach to Combating Antimicrobial Resistance
The AMR Industry Alliance has developed a science-based standard known as the Predicted No-Effect Concentration (PNEC), which sets discharge limits for antibiotic manufacturing....
Why Pharmaceutical Companies Must Prioritize Women in Management
Research indicates that businesses with women in high-ranking positions often enjoy greater profitability and stronger financial success....
Reducing API Independence in India
Only 2 of the 53 critical APIs have 60 percent of their requirements met by domestic suppliers along with the price difference compared to imports exceeding 20 percent....
Blog
Latest news in...
Drug Discovery & Development
- - Cyrano Therapeutics Completes Enrollment in Phase 2 FLAVOR Trial of CYR-064 for Post-Viral Smell Loss
- - ProFuse Launches Drug Discovery Platform for Prevention of Muscle Loss
- - IRBM Expands Functional Genomics Platform to Boost Early Drug Discovery
- - Astellas and Japanese Foundation for Cancer Research to Accelerate Clinical Oncology Research
Keywords
Talking about...
Next events
Appointments
Saumen Chakraborty, Member Board of Directors, PREMAS BIOTECH
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Silvia Steyrer-Grube, Chief Executive Officer, CEO, Coriolis Pharma
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy